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1. Introduction 
Proteins can be covalently modified by ubiquitin. These modifications are the result of a 
coordinated enzymatic process and regulate many cellular networks and processes 
(Schwartz & Ciechanover, 2009, Weissman et al., 2011). First, ubiquitin is activated by an 
ubiquitin activating enzyme (E1), then the activated ubiquitin is transferred to the active 
cysteine of an ubiquitin conjugating enzyme (E2), which interacts with a substrate 
recognizing enzyme, the ubiquitin ligating enzyme (E3). This enzyme positions ubiquitin 
towards the substrate, after which ubiquitin is covalently linked via its C-terminal glycine 
residue to the ε-amino group of a lysine residue. The human genome contains two E1, 35 E2, 
and more than 1000 E3 enzymes. The E3s are subdivided in three types: Hect, Ring and U-
box domain containing. Ubiquitin has seven internal lysine residues that can be modified 
with ubiquitin, resulting into chains of multiple ubiquitin moieties. Depending on the 
internal lysine that is modified, different types of ubiquitin chains can be synthesized. The 
most abundant ubiquitin chains are linked via lysine-48 (K48), lysine-63 (K63), or 
combinations, resulting in mixed chains (Goto et al., 2010). Additionally, it was recently 
discovered that linear ubiquitin chains are important in NFκB activation. These chains are 
formed by LUBAC (“linear ubiquitin chain-assembly complex”), by conjugating ubiquitin 
moieties head-to-tail (Iwai K & Tokunaga, 2009, Rahighi et al., 2009). Substrates can be 
modified by one ubiquitin moiety (mono-ubiquitylation), by one ubiquitin moiety on more 
than one lysine in the same substrate (multiple mono-ubiquitylation) or by chains of 
ubiquitin (poly-ubiquitylation). Analogous to phosphorylation, ubiquitin can be removed 
from substrates. A special class of proteases, the deubiquitylating enzymes (DUBs) of which 
there are approximately 100 genes in the human genome, can specifically remove ubiquitin 
moieties (reviewed in Soboleva & Baker, 2004).  Modification by ubiquitin can have several 
outcomes for a substrate protein. Besides degradation by the proteasome, ubiquitin 
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modification can regulate a.o. DNA repair as well as sorting of transmembrane proteins, 
which is the topic of this chapter. Clathrin mediated endocytosis, a well characterized mode 
of endocytosis of membrane and cargo molecules, involves the recognition of cargo, 
assembly of the coat and the pinching off of the invagination (Marsh & McMahon, 1999). 
The cargo is acquired by adapter proteins such as AP-2 or by AP-2 binding proteins such as 
Epsin1 or Eps15, after which the clathrin lattice is formed and the membrane is curved by 
BAR domain-containing proteins (Kirchhausen, 1999). The curved domain is pinched off by 
dynamin and forms a cargo-containing coated vesicle. Subsequently, this vesicle is uncoated 
and fused with early endosomes (van der Bliek et al., 1993). From the early endosomes the 
cargo can either be transported toward the lysosome, ultimately resulting in degradation, or 
recycled back to the plasma membrane. These decisions are mediated by three endosomal 
sorting complexes, ESCRT-I, -II and -III (Jovic et al., 2010). 
The involvement of ubiquitin in membrane traffic was first described in yeast, where 
ubiquitylation of both the α-factor receptor and carboxypeptidase S by the HECT E3 ligase 
Rsp5 is essential for endocytosis as well as for their correct trafficking into the multi 
vesicular bodies (MVB) (Hicke & Riezman, 1996). In mammalian cells, the role of ubiquitin 
was first studied for the growth hormone (GH) receptor and the sodium channel ENaC 
(Staub et al., 1996, Strous et al., 1996). ENaC is ubiquitylated by the HECT E3 Nedd4-2 and is 
subsequently recognized by the ubiquitin binding domain containing clathrin adapter 
Epsin1. After endocytosis, deubiquitylation of ENaC by the DUBs UHC-L3 and USP2 
determines its fate at the multivesicular bodies. ENaC that remains ubiquitylated is 
recognized by the ESCRT complexes and degraded in the lysosome, whereas 
deubiquitylated ENaC is recycled back toward the plasma membrane (Butterworth & 
Johnson, 2008). A second DUB involved in ENaC down regulation is USP10, which can 
deubiquitylate sorting nexin 3, resulting in both decreased ENaC endocytosis and increased 
recycling. USP10 is also implied in endocytosis and recycling of the cystic fibrosis 
transmembrane conductance regulator CFTR (Bomberger et al., 2010, Boulkroun et al., 2008).  
The role of ubiquitylation in endocytosis of receptor tyrosine kinases has been extensively 
studied for the tyrosine kinase receptor, the epidermal growth factor (EGF) receptor. The 
RING E3 ligase c-Cbl and the E2 enzyme Ube2D1-4 are involved in ubiquitylation of the 
EGF receptor. Its clathrin-dependent endocytosis is regulated via binding to the clathrin 
adapter AP-2, either directly or via the ubiquitin binding endocytosis adapter Eps15 or 
Epsin1. Ubiquitin plays also an important role in sorting of the EGF receptor from the 
endosomal system toward the lysosome. This receptor is actively sorted away from the 
recycling endosome by binding to Hrs, which in turn binds the flat clathrin coat on the 
endosome (Madshus & Stang, 2009). Hrs binds to the ESCRT-I component Tsg101 that 
delivers the EGF receptor to the ESCRT machinery. Incorporation of the EGF receptor into 
intraluminal vesicles depends on the DUBs AMSH and USP8 that are associated with the 
ESCRT-III machinery (Row et al., 2007). However, other studies have shown that USP8 can 
also act , earlier at the level of ESCRT-I, by preventing entry into multivesicular bodies 
promoting recycling. The interaction of USP8 to both ESCRT-I and ESCRT-III indicates a 
complex role for this DUB in sorting of endosomal cargo (Berlin et al., 2010). 
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For the cytokine receptors interferon-α receptor chain 1 (IFNAR1), the prolactin, the 
erythropoietin and GH receptor, βTrCP, the substrate recognizing subunit of the E3 ligase 
complex skip-culling-F-box (SCF), is essential for endocytosis and degradation (Kumar et 
al., 2004, Li et al., 2004, Meyer et al., 2007, van Kerkhof et al., 2007). Clearly, cytokine 
receptors appear particularly well regulated by the ubiquitin system. To identify additional 
regulators of ubiquitylation events involved in trafficking of cytokine receptors we used our 
model, the GH receptor. 
The GH receptor plays an important role in growth and metabolic pathways. In contrast to 
the EGF receptor, the GH receptor is constitutively endocytosed and degraded in lysosomes. 
Using a temperature-sensitive E1 mutant, we previously showed that endocytosis is 
clathrin-mediated and depends on an intact ubiquitin system (Strous et al., 1996). This 
activity is mediated via the ubiquitin-dependent endocytosis (UbE) motif, a 12 amino acid 
stretch in the cytosolic tail of the GH receptor (Govers et al., 1999). The ring E3 ligase 
SCF(βTrCP) binds to the UbE motif and this binding is required for proper endocytosis (van 
Kerkhof et al., 2007). Recently, it was shown that, in addition to endocytosis, βTrCP is 
involved in sorting the GH receptor from multivesicular bodies towards the lysosome (van 
Kerkhof et al., 2011). In the absence of βTrCP, transport of the GH-GH receptor complex is 
halted at the multivesicular bodies and routed back to the plasma membrane. Interestingly, 
ubiquitylation of the receptor itself is not required for proper sorting, but it does require 
binding of this E3 ligase. These findings suggest that the GH receptor travels from the cell 
surface to the lysosome using βTrCP as a cargo-specific adapter that ubiquitylates (an 
ancillary factor of) the machinery instead of the cargo itself. In this study we used small 
interfering ribonucleic acid (siRNA) in a cell-based assay to find additional regulators of 
ubiquitylation involved in the fate of GH receptors expressed at the cell surface. We 
screened a library of siRNAs targeting DUBs and other ubiquitylation factors for their 
involvement in GH receptor sorting towards the lysosomes. 
2. Materials and methods 
2.1. Antibodies, chemicals, and cells 
The DUB siRNA library (Table 1) was obtained from Dharmacon, Thermo Scientific. Anti 
GH receptor (B) was previously described (van Kerkhof et al., 2000). Anti-actin was 
obtained from ICN. Lipofectamine2000 was obtained from InVitrogen. Butyrate was 
obtained from Sigma. NHis6-GH receptor expressing HepG2 cells ware grown in MEM 
(InVitrogen), supplemented with 10% FCS, 100 units/ml penicillin and 0.1 mg/ml 
streptavidin and geneticin.  GH receptor U2OS cells were generated and propagated as 
described in van Kerkhof et al., 2011. 
2.2. SiRNA transfection and screening  
Mixtures of 0.07 µl lipofectamine2000 and siRNAs in a total volume of 10 µl Optimem with 
a final concentration of 48 nM siRNA per well (348 well plates) were incubated for 30 min at 
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room temperature. Four thousand Nhis6-GH receptor expressing HepG2 cells were added 
to the mixture and allowed to propagate. After 48 h, 10 mM butyrate was added to increase 
the expression of GH receptor. After 72 h, the cells were incubated at 37°C with 5 ng/µl Cy3-
GH for 30 min, and fixed with 3% paraformaldehyde for 4 h at room temperature. After 
three 5-min washes with PBS, cells were incubated with 50 µl DAPI, 0.5 µg/ml for 10 min 
and washed with PBS. Automated image acquisition was performed by the BD Pathway 855 
system (BD Bioscience). DAPI was used for focusing and 4 images per well were acquired 
using a 20x objective. 
 
Gene 
Symbol 
Accession 
Number 
Gene 
Symbol 
Accession 
Number 
Gene 
Symbol
Accession 
Number 
Gene 
Symbol 
Accession 
Number 
ATXN3L XM045705 UBE1C NM003968 UBL4 NM014235 USP33 NM015017 
BAP1 NM004656 UBE1DC1 NM024818 UBL5 NM024292 USP34 XM291018 
COPS5 NM006837 UBE1L NM003335 UBR1 NM174916 USP35 XM290527 
CXORF53 NM024332 UBE2A NM003336 UBTD1 NM024954 USP36 NM025090 
CYLD NM015247 UBE2B NM003337 UCHL1 NM004181 USP37 NM020935 
DUB1A XM377830 UBE2C NM007019 UCHL3 NM006002 USP38 NM032557 
DUB3 NM201402 UBE2D1 NM003338 UCHL5 NM015984 USP39 NM006590 
FBXO7 NM012179 UBE2D2 NM003339 UEV3 NM018314 USP4 NM003363 
FBXO8 NM012180 UBE2D3 NM003340 UFD1L NM005659 USP40 NM018218 
FLJ14981 NM032868 UBE2E1 NM003341 USP1 NM003368 USP41 XM036729 
JOSD1 NM014876 UBE2E2 NM152653 USP10 NM005153 USP42 XM166526 
LOC391622 NM212553 UBE2E3 NM006357 USP11 NM004651 USP43 XM371015 
MJD NM004993 UBE2G1 NM003342 USP12 NM182488 USP44 NM032147 
MYSM1 XM055481 UBE2G2 NM003343 USP13 NM003940 USP45 XM371838 
OTUB1 NM017670 UBE2H NM003344 USP14 NM005151 USP46 NM022832 
OTUB2 NM023112 UBE2I NM003345 USP15 NM006313 USP47 NM017944 
OTUD1 XM166659 UBE2J1 NM016021 USP16 NM006447 USP48 NM033236 
OTUD4 NM017493 UBE2J2 NM058167 USP18 NM017414 USP5 NM003481 
OTUD5 NM017602 UBE2L3 NM003347 USP19 XM496642 USP50 NM203494 
OTUD6B NM016023 UBE2L6 NM004223 USP2 NM004205 USP51 NM201286 
OTUD7 NM130901 UBE2M NM003969 USP20 NM006676 USP52 NM014871 
PARP11 NM020367 UBE2N NM003348 USP21 NM012475 USP53 XM052597 
PRPF8 NM006445 UBE2NL XM372257 USP22 XM042698 USP54 NM152586 
PSMD14 NM005805 UBE2Q NM017582 USP24 XM165973 USP6 NM004505 
SBBI54 NM138334 UBE2R2 NM017811 USP25 NM013396 USP7 NM003470 
SENP2 NM021627 UBE2S NM014501 USP26 NM031907 USP8 NM005154 
SHFM3P1 AF174606 UBE2V2 NM003350 USP28 NM020886 USP9X NM004652 
STAMBP NM006463 UBE3A NM000462 USP29 NM020903 USP9Y NM004654 
STAMBPL1 NM020799 UBE3B NM130466 USP3 NM006537 VCPIP1 NM025054 
TNFAIP3 NM006290 UBE4A NM004788 USP30 NM032663 YOD1 NM018566 
TRFP NM004275 UBE4B NM006048 USP31 NM020718 ZA20D1 NM020205 
UBE1 NM003334 UBL3 NM007106 USP32 NM032582 ZRANB1 NM017580 
Table 1. DUB siRNA library. 2Underlined genes are ubiquitin-related proteins without DUB activity 
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2.3. Western blotting 
GH receptor expressing U2OS cells were transfected with the siRNAs to silence the 
indicated genes. Cells were lysed in 1% Triton X-100, 10 µg/ml leupeptin, 10 µg/ml aprotinin 
and 1 mM PMSF in PBS for 20 min and centrifuged at 13,000 x g for 5 min at 4°C. The 
supernatant was boiled in Laemmli sample buffer, and the proteins were separated on SDS-
PAGE and transferred to Immobilon-FL polyvinylidenedifluoride membrane (Millipore). 
Blots were immunostained with primary antibodies followed by Alexa Fluor 680 or IRDye 
800 conjugated anti-mouse or anti-rabbit antibodies. An Odyssey system was used for 
detection (Li-Cor Biosciences, Lincoln NE). 
3. Results 
3.1. High throughput screening 
GH receptor transport from the plasma membrane toward the lysosome is a complex 
process that requires, in addition to general endocytosis factors, specific regulatory proteins. 
As the ubiquitin system was implied in this process (Govers et al., 1997), we set up an assay 
to identify novel modifiers of regulatory ubiquitilation involved in GH uptake.  
Since the liver is an important target of GH, we used the human hepatocellular carcinoma 
cell line HepG2 for this assay. These epithelial cells are non-tumorigenic and synthesize a 
variety of liver-specific proteins, such as the asialoglycoprotein receptor and several plasma 
proteins (albumin, transferrin and the acute phase proteins fibrinogen, β2-macroglobulin, 
α1-antitrypsin, and plasminogen). Although HepG2 cells are GH sensitive, they have 
insufficient GH receptors to probe the effect of gene silencing. Therefore, we constructed a 
HepG2 cell line that expresses 100-200,000 rabbit GH receptors per cell. To identify genes 
involved in GH receptor endocytosis and degradation, we transfected the GH receptor 
expressing HepG2 cells with siRNAs as indicated. After 72 h, the cells were allowed to take 
up GH conjugated with Cy3 (Cy3-GH) for 30 min at 37°C, after which they were 
immediately fixed and assessed for Cy3-GH uptake (Fig. 1).  
We screened a commercial siRNA library targeting 84 DUBs and 44 other ubiquitylation-
related enzymes (Table 1) for regulators of GH uptake and receptor sorting (Dharmacon). 
This arrayed library consists of siRNA pools constituted of 4 unique siRNA sequences, 
targeting a specific gene (Dharmacon). The screen was performed in a 384 well plate format 
and an automated spinning-disc confocal microscope was used for unbiased image 
acquisition, 4 images per well, of Cy3-GH and DAPI signal. The experiment itself was 
performed in duplicate yielding eight data points per gene. Hits were called when at least 3 
out of 4 wells showed a similar phenotype. The assessment of hits was done manually in a 
double blind fashion by two researchers, independently. The hits were ordered in three 
categories: Category I, Cy3-GH enrichment on the plasma membrane, category II, Cy3-GH 
enrichment on both the plasma membrane and intracellular, and category III, intracellular 
enrichment only. Clathrin heavy chain and Tsg101 depletion, involved in clathrin-mediated 
endocytosis and in sorting at multivesicular bodies, respectively, were used as controls. Fig. 
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1 (first row) shows that clathrin depletion resulted in accumulation of Cy3-GH at the plasma 
membrane, whereas Tsg101 depletion resulted in Cy3-GH accumulation in both internal 
vesicles and on the plasma membrane. These data show that our screen setup has sufficient 
sensitivity to detect accumulation of GH receptor. Using the same method we identified 13 
genes: 7 in category I, 3 in category II and 3 in category III (Table 2). The E1 enzyme (UBE1) 
was identified as a category I hit, in concordance with its previously described role in GH 
receptor endocytosis (Strous et al., 1997) 
 
Figure 1. Representative images of observed phenotypes in the screen. Cells were transfected with 
smartpool siRNA, containing 4 individual siRNAs directed against a specific target. After 72 h, cells 
were incubated with Cy3-GH at 37°C for 30 min and fixed. Four images of the samples were 
automatically acquired, and analysed by eye. All the targets that were considered hits are shown. The 
image is a representative of 2 experiments. The images are grouped according to three pheno-typical 
categories: I: Cy3-GH enrichment on the plasma membrane, II: Cy3-GH enrichment on both the plasma 
membrane and intracellular, and III: intracellular enrichment only. 
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Gene Protein Function Cat 
USP19 
Ubiquitin carboxyl-terminal 
hydrolase 19 
DUB functioning in ER folding 
 
I 
MJD Ataxin-3 
DUB functions in IGF-1 signalling and 
longevity in C. Elegans 
I 
USP30 Ubiquitin specific protease 30 
DUB located at outer mitochondrial 
membrane, function unknown 
I 
OTUD6B OTU domain containing 6B 
Member of the otubain DUB family, 
function unknown 
II 
PARP11 
poly (ADP-ribose) polymerase 
family, member 11 
Poly (ADP-ribose) polymerase family 
member, mRNA processing 
I 
PRPF8 
pre-mRNA processing factor 8 
(PRPF8 homolog, yeast) 
mRNA processing factor functions in 
the spliceosome 
III 
UBE1 
Ubiquitin activating enzyme 
E1 
Human ubiquitin-activating enzyme E1 I 
USP52 Ubiquitin specific peptidase 52 DUB, function unknown I 
USP8 ubiquitin specific peptidase 8 
DUB, involved in EGF receptor sorting 
at multivesicular bodies 
II 
UBE2I 
ubiquitin-conjugating enzyme 
E2I  (UBC9 homolog, yeast) 
Human homolog of UBC9, activating 
enzyme for ubiquitin like protein 
SUMO 
III 
UBE2L3 
ubiquitin-conjugating enzyme 
E2L 3 
Ubiquitin conjugating enzyme, cell 
cycle, can function together with Triad1 
I 
UBE2N 
ubiquitin-conjugating enzyme 
E2N  (UBC13 homolog, yeast) 
Ubiquitin conjugating enzyme able to 
catalyse K-63 linked ubiquitin chains 
II 
UBL5 
ubiquitin-like protein 5 
(BEACON homolog, human) 
Ubiquitin like protein, differentially 
expressed between lean and obese 
III 
Table 2. Screening results: Genes with a phenotype 
3.2. Validation of hits 
To validate candidate genes, we tested 8 siRNA pools with the strongest phenotypes in the 
first screen (USP19, Ubc9, Usp52, Usp8, Ubc13, Ubl5, PRPF8, and OTUD6B) in a second 
screen using a different cell type. For this purpose, we transfected osteosarcoma U2OS cells 
with rabbit GH receptor and selected a clone that expressed a limited number of exogenous 
GH receptors (Fig. 2A). In our experience, U2OS cells have a limited capacity to endocytose 
cargo via the clathrin-mediated pathway, a feature that renders the endocytosis assay 
particularly sensitive. In addition to the siRNA pools we transfected the individual siRNAs 
that constituted the pools (data not shown). In all cases at least 2 out of 4 siRNAs showed a 
similar phenotype as the pool, decreasing the likelihood of off-target effects. These 8 hits 
were examined in more detail. 
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3.2.1. Usp19 
Usp19 depletion showed an overall increase in Cy3-GH signal as well as some cell surface 
labelling (Fig 2A). Usp19 is an ER-localized membrane protein (Hassink et al., 2009), which 
was originally identified as a DUB induced in atrophying muscle (Combaret et al., 2005). It 
stabilizes ER localized proteins like CFTR and TCRα (Hassink et al., 2009) as well as cytosolic 
proteins like Hif1α, Siah1 and 2, c-IAP1 and 2, and the cyclin-dependent kinase inhibitor 
regulating ubiquitin ligases KPC1 and 2 (Altun et al., 2012, Lu et al., 2009, Mei et al., 2011). 
Interestingly, the catalytic activity of USP19 does not seem to be required for the stabilization 
of its substrates, but for stabilization of itself, facilitated via self-association (Altun et al., Mei et 
al., 2011). It also modulates transcription of major myofibrillar proteins (Sundaram et al., 2009), 
probably in a similar way as the earlier mentioned proteins. Furthermore, Usp19 is 
upregulated in smoke-induced muscle atrophy conditions in mice (Liu et al., 2011).  
 
Figure 2. Validation of hits obtained by the initial screen. GH receptor expressing U2OS cells were 
transfected with siRNAs as indicated. A) After 72 h, the cells were allowed to take up Cy3-GH for 30 
min at 37°C and immediately fixed. Cy3-GH uptake was assessed by automated confocal microscopy; 
images are representative of 4 experiments. B) After 72 h, cells were lysed and proteins were separated 
by SDS-PAGE followed by Western blot analysis for GH receptor (GHR) using actin as a loading 
control.  The upper GHR band represents the mature GHR, while the lower band is the immature (ER) 
form. The ratio mature/immature for the GHR species was taken as a measure for the turnover of the 
GHR related to the steady state situation in control cells. 
 
Identification of Ubiquitin System Factors in Growth Hormone Receptor Transport 399 
Since the predominant splice variant is a type IV membrane protein, USP19 might act as an 
ER resident protein with no direct role in GH receptor regulation at the endosomal level. 
Further characterization was beyond the scope of this study. Alternative roles in the cytosol 
will undoubtedly become clear in the future. 
3.2.2. Usp8 
Usp8, also known as UBPY, is a deubiquitylating enzyme that functions in protein sorting at 
multivesicular bodies. Depletion of Usp8 showed a perinuclear accumulation of Cy3-GH 
punctae (Fig. 2A), reminiscent of the phenotype resulting from Tsg101 depletion. To 
characterize the effects of gene silencing on the GH receptor degradation further we 
performed Western blot analysis for the GH receptor. This approach reveals additional 
details related to the role of USP8 in GH receptor trafficking. At steady state, Western blot 
analyses of the GH receptor show an approximately 1:1 ratio of the amount of ‘immature’ 
(high mannose oligosaccharides-containing) receptor, mainly located in the rough ER, and 
the amount of the ‘mature’, complex-glycosylated GH receptor, mainly present at the 
plasma membrane. Previously, we determined the half-life of both GH receptor species to be 
50 min at 37°C. The half-life of the high-mannose GH receptor is defined as the time it takes 
for the GH receptor to exit the ER and arrive at the Golgi complex to receive the ‘complex’ 
sugar moieties, while the half-life of the ‘mature’ GH receptor is defined as the time 
required for its transport from plasma membrane to the lysosomes. As Usp8 depletion 
caused a relative increase in mature over immature GH receptor levels, the results suggest 
that Usp8 promotes GH receptor degradation. 
Usp8 can bind to ESCRT-III components and its depletion leads to enlarged endosomes 
and diminished incorporation of EGF receptors into the intraluminal vesicles (ILV) of the 
multivesicular bodies (Bowers et al., 2006). In addition, it has been reported that Usp8 
can interact with the ESCRT-0 component STAM via its SH3 domain and that its 
depletion results in accelerated degradation of EGF receptor in the lysosome, strongly 
suggesting that Usp8-dependent deubiquitylation of EGF receptor prevents EGF receptor 
from being recognized by the ESCRT machinery, a recognition depending on ESCRT-0 
component Hrs (Berlin et al., 2010, Rao et al., 2011). Furthermore, the ability of Usp8 to 
bind both ESCRT-I and ESCRT-III suggests a dual function for Usp8 in receptor sorting. 
Indeed, at the plasma membrane Usp8 can inhibit degradation of receptors by removing 
the ubiquitin tag that directs them to the multivesicular bodies, while at the 
multivesicular bodies Usp8 can promote degradation of receptors by allowing 
incorporation of receptors into the ILVs (Wright et al., 2011). We demonstrate here that 
depletion of Usp8 increases the level of intracellular GH receptor indicative of a defect in 
sorting towards the lysosome, most likely at the level of ESCRT-III. The latter is 
supported by previous data showing that the transport of GH receptor from 
multivesicular bodies to the lysosome does not depend on ESCRT-0 components. 
Apparently, the GH receptor enters the ESCRT complexes at the level of ESCRT-I (van 
Kerkhof et al., 2011). 
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3.2.3. Ubl5 
Ubl5 depletion leads to an increased accumulation of Cy3-GH in endosomes. The Western 
blot analyses showed a complex pattern wherein both the immature GH receptor band and 
the mature GH receptor were increased compared to control cells. Ubl5 is a small ubiquitin 
like modifier that, in contrast to other ubiquitin like molecules, does not have a C-terminal 
glycine residue. A remarkable finding implicated a mutation in non-coding regions of Ubl5 
in metabolic syndrome-related phenotypes (Bozaoglu et al., 2006). In a recent study, Mishra 
and co-workers show that its yeast homologue Hub1 alters the splice specificity for certain 
non-canonical 5' splice sites by non-covalent attachment to elements of the spliceosomes 
(Mishra et al., 2011). Combining the above renders it plausible that expression levels of Ubl5, 
altered by mutations in the non-coding region, attenuate the expression of proteins 
ultimately affecting metabolism. Since the GH receptor is tightly involved in regulation of 
metabolic pathways, the involvement of Ubl5 in GH receptor trafficking toward the 
lysosome is interesting. Either the GH receptor itself or GH receptor-regulating factors 
might be affected by Ubl5. Preliminary data from 125I-GH uptake experiments suggest that 
depletion of Ubl5 does not alter the internalization and degradation kinetics of the receptor.  
Furthermore, a direct interaction between the GH receptor and Ubl5 could not be identified 
(data not shown). Since steady state levels of GH receptor as measured with Western blot 
analyses did increase as a result of Ubl5 silencing (Fig. 2B), the data suggest that Ubl5 either 
influences transcription or synthesis of the GH receptor. To fully understand the role of 
Ubl5 more investigation is required. 
3.2.4. PrPF8 
Pre-mRNA-processing-splicing factor 8 (PrPF8) is a large nuclear protein that functions in 
the U2, U12 and trans-spliceosome, and has an active role in processing of pre-mRNA 
(reviewed in Grainger & Beggs, 2005). PrPF8 knockdown showed an intracellular 
accumulation of Cy3-GH. In addition, the Western blot analysis showed an increase in the 
immature form of GH receptor and a complex band pattern of slower migrating bands. 
This might indicate that multiple pathways are affected. Because of PrpF8’s role in the 
spliceosome, it is likely that depletion of this protein can influence correct splicing of 
many factors including the GH receptor and proteins of the endocytosis machinery. We 
did not yet elucidate whether PrPF8 is directly or indirectly involved in GH receptor 
endocytosis. For example, previously, we have shown that alternative splicing of βTrCP 
isoforms may affect their localization, which may have consequences for GH receptor 
endocytosis (Putters et al., 2011b). Because the GH receptor mRNA was artificially 
transcribed from a plasmid driven by a CMV promoter (pcDNA3) it is possible that this 
might indirectly lead to alterations in sorting of GH receptor at the plasma membrane or at 
endosomes by exceeding the sorting capacity of these systems. Alternatively, absence of 
PrPF8 may affect the balance of folding factors in the ER, resulting in ER overload of GH 
receptors that cannot leave the ER, e.g. due to defective dimerization (van den Eijnden et 
al., 2006). 
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3.2.5. OTUD6B 
Ovarian tumour (OTU) domain containing 6B (OTUD6B) is a member of the OTU-domain 
Ubal-binding protein (otubain) domain containing protein family that constitutes a specific 
subset of deubiquitylating enzymes. The function of OTUD6B is not known. Substrates of 
two other OTU domain containing proteins, OTUB1 and OTUB2, are GRAIL (Soares et al., 
2004), oestrogen receptor (Stanisic et al., 2009), p97 (Ernst et al., 2009), RhoA (Edelmann et 
al.), Traf3 and Traf6 (Li et al., 2010). They have been implicated in non-canonical DNA-
damage response (Nakada et al., 2010). Furthermore, OTUB1 shows substrate specificity 
towards K48 linked ubiquitin chains (Wang et al., 2009). We have identified OTUD6B as a 
novel factor in GH receptor endocytosis. Its depletion leads to a phenotype where mature 
GH receptor accumulates, mainly in the endosomes but also at the plasma membrane. Fig. 
2B clearly shows a decreased degradation with little effect on its biosynthesis. Analogous to 
Tsg101 depletion, this might point to a role in multivesicular body function. Further 
investigations are necessary to determine whether OTUB6D acts specific on the GH receptor 
or has a general role in endosomal sorting. 
3.2.6. Ubc13 and associated E3s 
The presence of UBE2N, encoding for the E2 enzyme Ubc13, in our hit list was striking. 
Previously, after our finding that ubiquitylation is required for GH receptor endocytosis and 
degradation, we identified SCF(βTrCP) as an E3 that specifically binds to the UbE motif of 
the GH receptor and conjugates K48 poly-ubiquitin chains to the GH receptor (Putters et al., 
2011a, van Kerkhof et al., 2007). With the identification of Ubc13 it became plausible that 
also K63-linked ubiquitin chains might be involved in GH receptor endocytosis, as Ubc13 
together with the pseudo E2s UEV1A and MMS2 can synthesize K63 linked ubiquitin chains 
(Deng et al., 2000).  
 
Gene Protein Function Reference
ARIH2* Triad1 Cell cycle, cell growth (Marteijn et al., 2009) 
CHFR* CHFR Cell cycle (Bothos et al., 2003, Loring et al., 2008) 
PARK2* Parkin 
Neuroprotection, cell 
death 
(Lo Bianco et al., 2004) 
RNF8* RNF8 DNA repair (Plans et al., 2006) 
Rad5 Rad5 DNA repair (Torres-Ramos et al., 2002) 
Rad18 PCNA DNA repair (Ulrich & Jentsch, 2000) 
STUB1* CHIP Heat shock system (Zhang et al., 2005) 
TRAF2 Traf2 TNF signalling (Habelhah et al., 2004) 
TRAF6 Traf6 TNF signalling (Wooff et al., 2004) 
Table 3. E3 ligases known to interact with Ubc13 
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Furthermore, these K63-linked ubiquitin chains have been implied in endocytosis in yeast 
(Lauwers et al., 2009) and in mammalian cells (Kamsteeg et al., 2006). To investigate 
whether K63-linked ubiquitylation is indeed involved in GH receptor endocytosis, we 
selected nine E3 ubiquitin ligases that are known to interact with Ubc13 (listed in Table 3) 
(Bothos et al., 2003, Deng et al., 2000, Loring et al., 2008, Marteijn et al., 2009, Plans et al., 
2006, Sun et al., 2004, Torres-Ramos et al., 2002, Zhang et al., 2005). As gene silencing of 
Traf2 and Traf6 induced cell death in previous experiments (data not shown), and rad5 and 
rad18 are mainly involved in DNA repair, we excluded them from further investigation and 
performed gene silencing experiments for the 5 remaining E3 ligases using validated 
siRNAs (Table 3, asterisk).  
We transfected GH receptor-expressing U2OS cells with these siRNAs and propagated them 
for 3 days prior to performing the assay as described above. Cells, treated with siRNAs for 
ARIH2 and STUB1, encoding Triad1 and CHIP, respectively, showed a strong phenotype 
(Fig. 3). Not only was the label intensity much higher, silencing of both genes also induced 
accumulation of Cy3-GH signal on the plasma membrane. Recently, we published details 
about the role of the ubiquitin ligase CHIP in GH receptor endocytosis involving a direct 
interaction with specific amino acid sequences in the cytosolic tail of the receptor. The same 
study shows that CHIP acts in collaboration with UBC13, implicating K63-specific 
ubiquitylation in the GH receptor endocytosis (Slotman et al., 2012). This is in accordance 
with Fig. 2.  
 
 
 
Figure 3. Mini-screen for E3s involved in Ubc13 mediated ubiquitylation. GH receptor-expressing 
U2OS cells were transfected with validated siRNAs targeting 5 E3 ligases that can function together 
with the E2 Ubc13. After 72 h, the cells were allowed to take up Cy3-GH at 37°C for 30 min after which 
they were fixed. Cy3-GH uptake was assessed by confocal microscopy. Shown cells are representative 
for all cells in the samples of 2 independent experiments. 
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Triad1-depleted cells showed larger internal vesicles with an altered pattern as compared 
to wild type. Triad1 is an E3 ligase that has 2 RING domains and, consequently, has the 
ability to bind two ubiquitin conjugases. Previously, Marteijn and co-workers identified 
both Ubc13 and UbcH7 as E2s involved in Triad1 action (Marteijn et al., 2009). As seen in 
Fig. 1 and Table 2, UBCH7 (UBE2L3) also tested positive in our initial screen, 
strengthening the involvement of Triad1 in the sorting of GH receptors in endosomes  
(Fig. 1, Table 2) 
In conclusion, we identified three novel genes in GH-induced endocytosis via the GH 
receptor, two of which (UBC13 and STUB1) demonstrated identical phenotypes, while 
silencing of ARIH2 resulted in a different pattern. All three enzymes are involved in K63-
linked ubiquitin chain formation. Further studies are being performed to determine whether 
ARIH2 acts specifically on the GH receptor or whether it has a broader function in 
endocytosis and/or lysosomal degradation (Hassink et al., 2012). 
4. Discussion 
We performed a siRNA screen in which we assayed 84 DUBs and 44 other enzymes of the 
ubiquitin and related systems. In the first screen we identified 13 genes that showed an 
altered uptake or degradation pattern of Cy3-GH. As expected, the UBE1 gene, encoding the 
E1 enzyme, one of two ubiquitin activating enzymes in mammalian cells, was among the 13 
hits. It is known that by disrupting the enzymatic activity of the E1 enzyme GH receptor 
endocytosis is blocked (Strous et al., 1996). The observation that E1 silencing results in a 
similar phenotype shows that the screen setup is valid and able to pick up factors of the 
ubiquitin system that are involved in (GH receptor) endocytosis. Furthermore, the large 
number of hits in this screen clearly shows that GH receptor trafficking by ubiquitin is a 
complex and well regulated process.  
Among the proteins that did not appear in our screen as a hit, but would be expected to 
show a phenotype, is the activating enzyme (E1) of the ubiquitin like modifier ISG15. 
ISG15ylation of Ubc13 disrupts its function (Zou et al., 2005) and depletion of this E1 would 
lead to less ISG15ylation of Ubc13 that might result in an increased endocytosis of GH 
receptor. Unfortunately, our approach lacks the sensitivity to register accelerated 
endocytosis. An assay that would pick up such an effect must be suited to measure 
endocytosis in a quantitative way rather than qualitatively. Another factor that we expected 
to find was UBE2M, which functions as the E2 for neddylation of cullins, the modification 
by the ubiquitin like protein Nedd8. Cullin neddylation activates SCF(βTrCP), which is 
essential for GH receptor ubiquitylation and degradation (van Kerkhof et al., 2007). 
Recently, the ubiquitin conjugase UBE2F was identified as a Nedd8 conjugating enzyme 
(Huang et al., 2009). Therefore, UBE2M and UBE2F might have a redundant function, 
possibly explaining the absence of UBE2M among our hits. Of note, UBE2F was not targeted 
by our siRNA library and was therefore not tested in our assay. 
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The screen identified two proteins involved in ubiquitin-like mechanisms, UBE2I, also 
known as UBC9, the E2 for SUMOylation, and UBL5, an ubiquitin like protein. This is the 
first time that these two pathways are implicated in GH receptor trafficking. Many 
similarities exist between the ubiquitin-based and ubiquitin-like mechanisms with many 
examples of interplay. In GH receptor trafficking SUMOylation might block ubiquitylation 
and vice versa (Denuc & Marfany, 2010). The action of UBL5 is more mysterious, since it 
cannot be conjugated to substrates due to a lack of a C-terminal glycine residue. 
Hypothetically, ubiquitin binding domains could be blocked by the structurally very similar 
UBL5 and in this a way UBL5 may regulate ubiquitylation events (McNally et al., 2003). A 
correlation between obesity and UBL5 mRNA levels was found in P. obesus (Walder et al., 
2002) but this finding is still debated in humans (Bozaoglu et al., 2006, McNally et al., 2003). 
Since GH receptor signalling is highly involved in growth and obesity (Erman et al., 2010, 
Gao et al., 2010), altering the sorting of GH receptor could be involved. Hence, GH receptor 
sorting defects, UBL5, and growth and metabolic diseases may be linked.  
We identified two novel ubiquitin ligases that are involved in GH receptor trafficking, CHIP 
and Triad1; thus, together with SCF(βTrCP), at least three E3s have a regulatory role in GH 
receptor degradation. This indicates that both K48 and K63-linked ubiquitin chain formation 
are involved. In addition, we identified six DUBs involved in GH receptor endocytosis and 
homeostasis: USP19, MJD, USP30, OTUD6B, UPS52 and USP8. These DUBs might 
antagonize the action of the ligases mentioned above, providing a high level regulation. 
Together, these proteins are part of a complex system that regulates ubiquitylation of many 
substrates. In part by spatial en temporal regulation, ubiquitylation and deubiquitylation 
events modulate the sorting of GH receptor, and thereby respond quickly to different forms 
of stress. Additionally, the number of distinct E2, E3, and DUB enzymes involved in 
ubiquitylation provides specificity in regulating different classes of receptors in disparate 
ways within the same endocytic system. 
These findings underscore the complexity of the ubiquitylation system and endocytosis 
process, and, at the same time, offer interesting opportunities to discover drugs that 
specifically target the GH receptor. As this receptor is implicated both in anabolism, in 
longevity and insulin sensitivity (Bartke, 2012), drugs that can either up- or down regulate 
its activity are highly relevant.  
5. Conclusion  
The ubiquitin proteasome system plays an essential role in trafficking of the growth 
hormone receptor from the plasma membrane to the lysosomes, where degradation takes 
place. When ubiquitylation is disabled, the GH receptor accumulates at the plasma 
membrane and its degradation is inhibited. As endosomal sorting is a highly regulated 
process that depends on a variety of ubiquitylation events, we set up a cell-based, high 
content siRNA screen targeting 128 genes of the ubiquitylation system. In this study we 
report the identification of 13 modifiers of regulatory ubiquitylation events that are involved 
in trafficking and degradation of the GH receptor. As the GH receptor is a key regulator of 
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metabolism, this study highlights the complexity of pathways that underlie its regulation. 
These findings may guide the development of specific drugs that either up- or down-
regulate GH-based signal transduction. As GH signalling is implicated in longevity, insulin-
sensitivity, and cancer, studies focussed at factors that regulate ubiquitylation and GH 
receptor levels are highly relevant. 
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